Suppr超能文献

298例动脉导管未闭极低出生体重儿的预后分析。

Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus.

作者信息

Alexander Frederick, Chiu Louisa, Kroh Matthew, Hammel Jeffrey, Moore John

机构信息

Hackensack University Medical Center, Hackensack, NJ 07601, USA.

出版信息

J Pediatr Surg. 2009 Jan;44(1):112-7; disscusion 117. doi: 10.1016/j.jpedsurg.2008.10.019.

Abstract

PURPOSE

Indomethacin is accepted therapy for patent ductus arteriosus (PDA) in ELBW infants (<1000 g). We hypothesize that surgical ligation may provide comparatively superior outcomes in select ELBW infants.

METHODS

Predischarge outcomes of 298 ELBW infants with echocardiography-proven PDA were retrospectively compared by treatment provided: no treatment (group 1, n = 54), indomethacin (group 2, n = 140), ligation (group 3, n = 46), and ligation after indomethacin failure (group 4, n = 58). chi(2) and Wilcoxon rank sum tests were used to test for significance. Institutional review board approval was obtained (IRB/05-00395).

RESULTS

Group 3 had significantly lower gestational age (P < .001), birth weight (P = .006), and 5-minute Apgar scores (P = .03) compared with group 2. Group 3 and group 1 had a higher rate of pretreatment intraventricular hemorrhage (IVH) compared with group 2 (P < .001). By contrast, posttreatment complications including acute renal failure, necrotizing enterocolitis, thrombocytopenia, and IVH occurred more frequently in groups 2 (P = .004) and 4 (P = .001) compared with group 3. Survival was 57.7% in group 1 compared with groups 2, 3, and 4 (82.4%, 86.0%, and 92.7% respectively; P = .001). Preoperative conditions associated with nonsurvival include gestational age (P = .009), birth weight (P = .002), maternal preeclampsia (P = .015), 5-minute Apgar score (P = .013), and sepsis (P = .018). Posttreatment complications associated with nonsurvival include acute renal failure (P = .002), thrombocytopenia (P = .002), and necrotizing enterocolitis (P = .034). Survival was not influenced by any congenital comorbidity, pre- or posttreatment IVH, diameter of the PDA, or recurrence of the PDA after indomethacin therapy.

CONCLUSIONS

(1) Patent ductus arteriosis requires treatment in ELBW infants to maximize survival. (2) Indomethacin and surgical ligation permit equivalent survival in low-risk ELBW infants, but indomethacin results in a high failure and complication rate requiring operative salvage in a number of patients. (3) Surgical ligation permits survival of high-risk ELBW infants with a low complication rate and is preferable to indomethacin in ELBW infants with the above risk factors.

摘要

目的

吲哚美辛是治疗极低出生体重(<1000g)婴儿动脉导管未闭(PDA)的公认疗法。我们假设手术结扎可能为部分极低出生体重婴儿带来相对更好的治疗效果。

方法

回顾性比较298例经超声心动图证实为动脉导管未闭的极低出生体重婴儿的出院前治疗效果,治疗方式包括:未治疗(第1组,n = 54)、吲哚美辛治疗(第2组,n = 140)、结扎手术(第3组,n = 46)以及吲哚美辛治疗失败后进行结扎手术(第4组,n = 58)。采用卡方检验和Wilcoxon秩和检验来检验差异是否具有统计学意义。研究获得了机构审查委员会的批准(IRB/05 - 00395)。

结果

与第2组相比,第3组的胎龄(P <.001)、出生体重(P =.006)和5分钟阿氏评分(P =.03)显著更低。与第2组相比,第3组和第1组治疗前发生脑室内出血(IVH)的比例更高(P <.001)。相比之下,第2组(P =.004)和第4组(P =.001)与第3组相比,治疗后并发症(包括急性肾衰竭、坏死性小肠结肠炎、血小板减少症和脑室内出血)的发生率更高。第1组的生存率为57.7%,与第2、3、4组(分别为82.4%、86.0%和92.7%;P =.001)相比更低。与未存活相关的术前情况包括胎龄(P =.009)、出生体重(P =.002)、母亲先兆子痫(P =.015)、5分钟阿氏评分(P =.013)和败血症(P =.018)。与未存活相关的治疗后并发症包括急性肾衰竭(P =.002)、血小板减少症(P =.002)和坏死性小肠结肠炎(P =.034)。生存率不受任何先天性合并症、治疗前或治疗后脑室内出血、动脉导管未闭直径或吲哚美辛治疗后动脉导管未闭复发的影响。

结论

(1)极低出生体重婴儿的动脉导管未闭需要治疗以提高生存率。(2)在低风险的极低出生体重婴儿中,吲哚美辛和手术结扎的生存率相当,但吲哚美辛治疗失败率和并发症发生率高,许多患者需要手术补救。(3)手术结扎可使高风险的极低出生体重婴儿存活且并发症发生率低,对于有上述风险因素的极低出生体重婴儿,手术结扎优于吲哚美辛治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验